Details for New Drug Application (NDA): 208920
✉ Email this page to a colleague
NDA 208920 describes LISINOPRIL, which is a drug marketed by Accord Hlthcare, Ascent Pharms Inc, Aurobindo, Chartwell Rx, Corepharma, Heritage Pharma, Hikma Intl Pharms, Invagen Pharms, Lupin, Prinston Inc, Rising, Sciegen Pharms Inc, Strides Pharma, Sun Pharm Inds Ltd, Teva, Watson Labs, Wockhardt Bio Ag, Epic Pharma Llc, Pharmobedient, and Sandoz, and is included in thirty-two NDAs. It is available from thirty-seven suppliers. Additional details are available on the LISINOPRIL profile page.
The generic ingredient in LISINOPRIL is hydrochlorothiazide; lisinopril. There are thirty-two drug master file entries for this compound. Twenty-nine suppliers are listed for this compound. Additional details are available on the hydrochlorothiazide; lisinopril profile page.
The generic ingredient in LISINOPRIL is hydrochlorothiazide; lisinopril. There are thirty-two drug master file entries for this compound. Twenty-nine suppliers are listed for this compound. Additional details are available on the hydrochlorothiazide; lisinopril profile page.
Summary for 208920
| Tradename: | LISINOPRIL |
| Applicant: | Sciegen Pharms Inc |
| Ingredient: | lisinopril |
| Patents: | 0 |
Pharmacology for NDA: 208920
| Mechanism of Action | Angiotensin-converting Enzyme Inhibitors |
Medical Subject Heading (MeSH) Categories for 208920
Suppliers and Packaging for NDA: 208920
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| LISINOPRIL | lisinopril | TABLET;ORAL | 208920 | ANDA | Chartwell RX, LLC | 62135-643 | 62135-643-31 | 300 TABLET in 1 BOTTLE (62135-643-31) |
| LISINOPRIL | lisinopril | TABLET;ORAL | 208920 | ANDA | Chartwell RX, LLC | 62135-643 | 62135-643-90 | 90 TABLET in 1 BOTTLE (62135-643-90) |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 20MG | ||||
| Approval Date: | Mar 4, 2021 | TE: | AB | RLD: | No | ||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 30MG | ||||
| Approval Date: | Mar 4, 2021 | TE: | AB | RLD: | No | ||||
Profile for product number 003
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 40MG | ||||
| Approval Date: | Mar 4, 2021 | TE: | AB | RLD: | No | ||||
Complete Access Available with Subscription
